We are live on ! Find out more
WX

WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX

Delisted

WX was delisted on the 10th of December, 2015.

Back to rankings

2 hedge funds and large institutions have $69K invested in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in 2015 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 148 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 151 → 2 (-149)

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 148

100% less funds holding in top 10

Funds holding in top 10: 14 → 0 (-14)

100% less capital invested

Capital invested by funds: $2.42B → $69K (-$2.42B)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-149
Holders Change %
-98.68%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
148
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CCS
Crosspoint Capital Strategies
California
+$2.83K

Top Sellers

Rank Fund Capital Flow
1
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$273M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$229M
3
O
OppenheimerFunds
New York
-$171M
4
Fidelity International
Fidelity International
Bermuda
-$148M
5
MICM
Matthews International Capital Management
California
-$116M
Name Holding Trade Value Shares
Change 		Change in
Stake
Aviva
101
Aviva
United Kingdom
– -$823K -19,052 Closed
QSS
102
Quantitative Systematic Strategies
Florida
– -$766K -17,731 Closed
Legal & General Group
103
Legal & General Group
United Kingdom
– -$717K -16,600 Closed
Stifel Financial
104
Stifel Financial
Missouri
– -$716K -16,562 Closed
Millennium Management
105
Millennium Management
New York
– -$696K -16,100 Closed
WPP
106
Whalerock Point Partners
Rhode Island
– -$662K -15,325 Closed
UBS AM
107
UBS AM
Illinois
– -$648K -15,000 Closed
GC
108
Guggenheim Capital
Illinois
– -$609K -14,096 Closed
D.E. Shaw & Co
109
D.E. Shaw & Co
New York
– -$597K -13,812 Closed
Bank of New York Mellon
110
Bank of New York Mellon
New York
– -$595K -13,759 Closed
SC
111
Saturna Capital
Washington
– -$531K -12,300 Closed
TI
112
Telemetry Investments
New York
– -$454K -10,500 Closed
JP Morgan Chase
113
JP Morgan Chase
New York
– -$447K -10,342 Closed
FMT
114
First Mercantile Trust
Tennessee
– -$445K -10,300 Closed
LPL Financial
115
LPL Financial
California
– -$444K -10,244 Closed
GPCM
116
Granite Point Capital Management
Massachusetts
– -$432K -10,000 Closed
AAM
117
Advisors Asset Management
Colorado
– -$393K -9,102 Closed
CS
118
Credit Suisse
Switzerland
– -$392K -9,067 Closed
VAM
119
Visium Asset Management
New York
– -$366K -8,471 Closed
Mirae Asset Global Investments
120
Mirae Asset Global Investments
South Korea
– -$366K -8,462 Closed
PC
121
Passport Capital
California
– -$352K -8,151 Closed
Bank of Montreal
122
Bank of Montreal
Ontario, Canada
– -$339K -7,864 Closed
Baillie Gifford & Co
123
Baillie Gifford & Co
United Kingdom
– -$321K -7,428 Closed
EDRAMF
124
Edmond de Rothschild Asset Management (France)
France
– -$279K -6,450 Closed
EDRH
125
Edmond de Rothschild Holding
Switzerland
– -$279K -6,450 Closed
2 3 4
5
6

WX Hedge Fund Activity: Q4 2015 in Review

2 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) for Q4 2015, worth a combined $69K — down 100% from $2.42B a quarter earlier.

Sellers outnumbered buyers: 148 funds closed out of WX and 1 opened new positions — a net loss of 147 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was Crosspoint Capital Strategies, opening a new position worth an estimated $2.83K. The largest seller was Schroder Investment Management Group, exiting entirely with an estimated $273M sold.

  • 2 institutional investors held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) as of Q4 2015, down from 151 in Q3 2015.
  • Funds reported $69K of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS stock for Q4 2015, down 100% quarter-over-quarter.
  • 1 fund opened new WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS positions in Q4 2015 and 148 closed out, a net change of -147 holders.
  • The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS buyer in Q4 2015 was Crosspoint Capital Strategies, an estimated $2.83K added.
  • The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS seller in Q4 2015 was Schroder Investment Management Group, an estimated $273M sold.

Based on aggregated 13F filings for Q4 2015.